The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
about
Molecular composition of IMP1 ribonucleoprotein granulesRNA-binding IMPs promote cell adhesion and invadopodia formation.Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation.Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesionExpression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systemsPrognostic value of high IMP3 expression in solid tumors: a meta-analysisLet-7b Regulates Myoblast Proliferation by Inhibiting IGF2BP3 Expression in Dwarf and Normal Chicken.Two isoforms of the mRNA binding protein IGF2BP2 are generated by alternative translational initiation.Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinomaIGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Role of the RNA-binding protein IMP-2 in muscle cell motility.Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequencesUp-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.Transcriptional profiling of mRNAs and microRNAs in human bone marrow precursor B cells identifies subset- and age-specific variations.mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entryInsulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.Differential expression of IMP3 between male and female mature teratomas--immunohistochemical evidence of malignant nature.Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodulesUpf1/Upf2 regulation of 3' untranslated region splice variants of AUF1 links nonsense-mediated and A+U-rich element-mediated mRNA decay.Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinomaRNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation.Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer.Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.Prognostic value of the IASLC/ATS/ERS classification and IMP3 expression in lung adenocarcinoma of Chinese casesModulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylationAn isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinomaInsulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
P2860
Q24296417-6B445F45-7EAD-463F-8D42-EA2E983A3994Q24542808-9C800836-65C7-42B1-8647-3819B97FC6BDQ24816630-33827FB2-B39C-44C1-BD7D-525E1338F386Q30540998-0C0A7796-8764-45F4-BACF-1B5A1C865D86Q30641525-47B41C36-CE1B-4AB4-B269-0B7C8BC33F79Q33274978-78E7AD47-B0AE-4123-BF00-C13BA2E9510BQ33608271-08858E64-9E4D-4F2A-B537-A671E4418DBDQ33621918-ED6A39C7-3DCA-4198-A73E-A2E7FFB25F18Q33772376-7C2A6D1C-C55B-47A3-BF94-9CA0198603EEQ33813288-82B3168E-33C0-4529-843A-12E7C93B7067Q33881851-206C8D55-B314-4363-90D0-C64EC5406FA4Q34200524-C9371F54-CCB9-44F3-A6A2-BC28A767F839Q34293287-C43E567F-81AE-4493-B573-7BDCF9C0533BQ34334410-FEE58746-D325-4076-B37B-9D71DC89CCD7Q34365135-45EDE261-79D9-490E-8241-C1BABE7558FEQ34416295-FFA4AD9D-3F06-4D5C-BCCC-4283737A7974Q34467904-4A0088E2-AE31-49C7-98B5-971A485A292DQ34505648-41FDA898-CB48-4321-9B44-73B77E69F7A3Q34728942-8323524B-C2C2-4BC6-87F2-14A189C77927Q34923498-3891B0A8-4A60-4380-91BF-CB6FE65B3652Q35033877-1F219674-E48A-424A-AFEA-65667319C620Q35110943-76F75C37-844F-420F-A9A8-3B470D7EE655Q35113770-4568642A-62DC-45A5-82DB-E31A4C33EB44Q35125481-27F426F7-CC13-4112-880B-85D42BA44D23Q35131592-39AE6F70-7100-4682-930D-F1A277F112E4Q35167573-737EC97D-5A8A-4088-9162-798928794AE8Q35213255-C77149FC-76E7-4CC9-94B2-C9DD2A41C274Q35607101-C4771F4B-3D3C-4BCD-B4F6-48C7AFCC9BEEQ35666404-861F8575-5819-43E8-BB44-1B795FBFC663Q35863071-60459FAE-D65E-45B6-8DB3-C69F5AA852D2Q35900481-4D47A423-B02E-4848-BFFF-6AD939BBAE8CQ35909674-56ED6835-77BF-41BA-9413-F395EF36077CQ35916537-174A6238-E9B6-4074-9A3D-05F62612C84BQ35993153-FD3E7B9D-0610-4A50-B975-8D5D070CC695Q36082658-51B30AFE-EF48-4A00-9D4E-3BDD9C5E1DF3Q36413135-6AF3ACA3-409F-4349-B6EF-97DCA0185308Q36517288-50625D14-87DC-40E9-B82B-4640BF78D36BQ36571435-BB9A420D-E970-43D5-942A-CCA687045C6EQ36723387-9D29AABC-A9FF-4CB7-908B-098BD1306697Q36733283-61164A26-922D-4FE0-BEF6-63967952837D
P2860
The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@ast
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@en
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@nl
type
label
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@ast
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@en
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@nl
prefLabel
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@ast
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@en
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@nl
P2093
P2860
P3181
P356
P1476
The RNA-binding protein IMP-3 ...... n of human K562 leukemia cells
@en
P2093
Baisong Liao
David J Herrick
Gary Brewer
P2860
P304
P3181
P356
10.1074/JBC.M500270200
P407
P577
2005-05-06T00:00:00Z